{{Rsnum
|rsid=6735786
|Chromosome=2
|position=103153780
|Orientation=plus
|GMAF=0.4036
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.0 | 42.5 | 11.5
| HCB | 15.3 | 46.0 | 38.7
| JPT | 13.3 | 36.3 | 50.4
| YRI | 85.0 | 14.3 | 0.7
| ASW | 78.9 | 19.3 | 1.8
| CHB | 15.3 | 46.0 | 38.7
| CHD | 11.9 | 40.4 | 47.7
| GIH | 34.7 | 49.5 | 15.8
| LWK | 61.8 | 34.5 | 3.6
| MEX | 20.7 | 44.8 | 34.5
| MKK | 80.8 | 17.9 | 1.3
| TSI | 48.0 | 41.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19079262
|Trait=Bone mineral density (hip)
|Title=New sequence variants associated with bone mineral density
|RiskAllele=C
|Pval=0.000002
|OR=0.07
|ORtxt=[0.04-0.09] SD decrease
}}

{{PharmGKB
|RSID=rs6735786
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19079262; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: New sequence variants associated with bone mineral density. (Initial Sample Size: 6,865 individuals; Replication Sample Size: 8,510 individuals); (Region: 2q12.1; Reported Gene(s): NR; Risk Allele: rs6735786-C); (p-value= 0.000002).This variant is associated with Bone mineral density (hip).
|Drugs=
|Drug Classes=
|Diseases=Bone Diseases; Bone Diseases, Metabolic
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740136
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6735786
|overall_frequency_n=34
|overall_frequency_d=122
|overall_frequency=0.278689
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}